El-Hibri Fuad Blog

Fuad El-Hibri Blog News

Thursday, August 6, 2009

Fuad El-Hibri On Muckety

Labels: Chief Executive Officer, Emergent BioSolutions, Fuad El-Hibri, fuad profiles, U.S. Food and Drug Administration, United States Department of Defense

Newer Post Older Post Home

Labels

Abdul Aziz Said (1)
academic (1)
Activism and Peace Work (1)
Aeras Global TB Foundation (1)
American Society of Hematology (2)
American University (2)
Anthrax (4)
anthrax vaccine (1)
Anthrax vaccines (19)
Arab world (1)
Atlanta (1)
award (3)
B-cell chronic lymphocytic leukemia (1)
BackType (1)
BARDA (1)
Bendamustine (1)
BERLIN (1)
biopharmaceutical (1)
biopharmaceutical company (1)
Biosolutions (1)
BioSolutions Inc (1)
Biotech (1)
Biotech CEO of the Year (1)
Biotechnology (1)
Biotechnology and Pharmaceuticals (3)
Biothrax (7)
BIOTHRAX® (2)
Board of directors (2)
Business (15)
Business Power 500 (1)
businessman (1)
california (1)
Centers for Disease Control and Prevention (2)
CEO (1)
Chairman (2)
Chairman of the Board (3)
Chief Executive Officer (31)
Chief financial officer (3)
Chief operating officer (1)
Clinical trial (7)
colleagues (1)
Colleges and Universities (1)
Colman McCarthy (1)
Common stock (1)
Company (1)
Conference call (2)
Corporation (1)
Crisis (1)
Daniel Heifetz (1)
DEPARTMENT OF HEALTH AND HUMAN SERVICES (1)
Dr. Mary Elizabeth King (1)
Education (1)
El Hibri Charitable Foundation (1)
el-hibri (2)
El-Hibri Peace Education Prize (4)
Emergent (1)
emergent Bioslutions (1)
Emergent BioSolutions (50)
Emergent Biosolutions Inc (3)
Employment (1)
entrepreneur (2)
Ernst Young (1)
European Parliament (1)
Executive (2)
Executive Profile (3)
Fair use (1)
finance (1)
Financial Results (1)
Food and Drug Administration (13)
Form 10-K (1)
fuad (1)
Fuad El-Hibri (43)
Fuad Elhibri (1)
fuad profiles (2)
Gene Sharp (1)
Global Healthcare Conference (1)
Harvard University (1)
Health (3)
Health care (1)
Healthcare Conference (2)
Heifetz International Music Institute (1)
Hematology (1)
Honors (1)
Hosni Mubarak (1)
http://projects.washingtonpost.com/post200/2007/executive/3921/ (1)
Hudson Institute (1)
Human rights (1)
Humanitarian aid (3)
Infectious disease (9)
International Biomedical Research Alliance (1)
Investor relations (1)
Investors (3)
Jascha Brodsky (1)
Kennedy (1)
Kofi Annan (1)
Leadership (2)
Lebanese (3)
Lebanon (1)
Leukemia (1)
Leukemia and Lymphoma Society (1)
Libraries (1)
Life Sciences Conference (1)
Lymphocyte (1)
Lymphoma (1)
Management (1)
Manufacturing (1)
Martin O'Malley (1)
Maryland (3)
Medical research (1)
Middle East (2)
muslims (1)
Nancy Ajram (1)
National Cancer Institute (1)
National Health Museum (1)
National Institute of Allergy and Infectious Diseases (2)
National Institutes of Health (2)
NATO (2)
Needham and Company Healthcare Conference (1)
New York Stock Exchange (2)
Nobel Peace Prize (1)
Non-Hodgkin lymphoma (2)
Non-profit organization (2)
North Atlantic Treaty Organization (1)
Organizations (1)
peace (2)
Pharmaceuticals (2)
Philanthropy (1)
Private Securities Litigation Reform Act (2)
profiles fuad (1)
Public health (2)
Research and development (3)
Research Scholars (1)
Rockville (3)
Rockville Maryland (4)
Santa Cruz (1)
Scholars Program (1)
Seattle (2)
Singapore Ministry of Health (1)
Social Network (1)
South Africa (1)
South African Tuberculosis Vaccine (1)
Stanford University (1)
Stock (1)
Strategic National Stockpile (2)
Systemic Lupus Erythematosus (1)
Takreem Achievement Awards (1)
TB (1)
TB Vaccine (1)
Tech Council of Maryland (1)
Technology (1)
Trubion Pharmaceuticals (2)
Tuberculosis (3)
Tuberculosis Consortium Vaccinates. (1)
U.S. Department of Health and Human Services (1)
U.S. Food and Drug Administration (5)
U.S. Government (1)
U.S. Securities and Exchange Commission (1)
United States (14)
United States Chamber of Commerce (1)
United States Department of Defense (3)
United States Department of Health and Human Services (4)
United States. (1)
University of Oxford (1)
US Food and Drug Administration (2)
US government (1)
Vaccination (2)
Vaccine (2)
VaxGen (1)
Vice president (2)
vilcek (1)
vileck foundation (1)
Wael Ghonim (1)
Washington (1)
Washington DC (2)
Washington Post (1)
Webcast (3)
Website (1)
World Health Organization (1)
Yale (1)
Yale University (2)

About Me

Fuad El-Hibri: Fuad El-Hibri, Chief Executive Officer and Chairman of the Board of Directors. Mr. El-Hibri has served as chief executive officer and chairman of the board of directors since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of our corporate reorganization, BioPort became a wholly owned subsidiary of Emergent.

View my complete profile

Blog Archive

► 2012 (4)
- ► April (1)
- ► March (1)
- ► February (2)

► 2011 (25)
- ► November (1)
- ► October (2)
- ► September (3)
- ► August (2)
- ► July (2)
- ► June (4)
- ► May (2)
- ► April (3)
- ► March (2)
- ► February (2)
- ► January (2)

► 2010 (25)
- ► December (2)
- ► November (2)
- ► October (2)
- ► September (2)
- ► August (4)
- ► July (5)
- ► June (2)
- ► May (2)
- ► April (1)
- ► March (2)
- ► January (1)

▼ 2009 (25)
- ► December (3)
- ► October (3)
- ▼ August (19)

Picture Window theme. Powered by Blogger.